StonvexLoading…
StonvexStonvexStonvexCore line items from WSO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-07-28 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $2.16B | $1.53B | $7.24B | $5.66B | $3.59B |
Operating Income | Not available | $110.18M | $720.35M | $618.82M | $384.06M |
Net Income | Not available | $79.07M | $496.99M | $425.25M | $263.67M |
EPS (Diluted) | $4.42 | $1.87 | $12.25 | $10.48 | $6.50 |
Total Assets | Not available | $4.65B | $4.41B | $4.55B | $4.73B |
Total Liabilities | Not available | Not available | Not available | Not available | Not available |
Cash & Equivalents | Not available | $392.68M | $433.28M | $324.35M | $292.98M |
Free Cash Flow OCF − CapEx | Not available | $-25.87M | $535.06M | $146.59M | $-199.47M |
Shares Outstanding | Not available | 37.96M | 37.90M | 37.89M | Not available |